Abstract
We compared the impact of a conditioning regimen with BU (n=16) or fractionated TBI (n=42) on height growth during adolescence and final height (FH), in 58 adults transplanted for acute leukaemia before adolescence (younger than 9 for girls and 11 for boys, and prepubertal). Heights were measured at three key periods, that is, transplantation, before adolescence, and FH, and compared using height standard deviation score (SDS) and cumulative change in SDS. The influence of the conditioning regimen was assessed using multiple linear regression and adjusting for gender, central nervous system irradiation, age and leukaemia status at transplant and type of transplantation. Overall mean height SDS was near normal at transplantation and before adolescence (0.2±0.1 and −0.2±0.1, respectively), but decreased to −1.6±0.1 at FH. There were significant differences between the TBI and BU groups when comparing FH SDS (−1.8±0.2 vs −0.8±0.2, P=0.001), mean change in height SDS from transplantation to FH (−2±0.1 vs −1.1±0.2, P=0.002) and mean change in height SDS during adolescence (−1.6±0.1 vs −0.7±0.2, P=0.003). We conclude that preparations involving BU, although less toxic than TBI-containing regimens, also have adverse effects on growth, predominantly during adolescence.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cicognani A, Cacciari E, Rosito P, Mancini AF, Carla G, Mandini M et al. Longitudinal growth and final height in long-term survivors of childhood leukaemia. Eur J Pediatr 1994; 153: 726–730.
Davies HA, Didcock E, Didi M, Ogilvy-Stuart A, Wales JK, Shalet SM . Growth, puberty and obesity after treatment for leukaemia. Acta Paediatr Suppl 1995; 411: 45–50.
Chow EJ, Friedman DL, Yasui Y, Whitton JA, Stovall M, Robison LL et al. Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Pediatr 2007; 150: 370–375.
Viana MB, Vilela MI . Height deficit during and many years after treatment for acute lymphoblastic leukemia in children: a review. Pediatr Blood Cancer 2008; 50: 509–516.
Fletcher BD, Crom DB, Krance RA, Kun LE . Radiation-induced bone abnormalities after bone marrow transplantation for childhood leukemia. Radiology 1994; 191: 231–235.
Michel G, Socie G, Gebhard F, Bernaudin F, Thuret I, Vannier JP et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation—a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 1997; 15: 2238–2246.
Socie G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003; 101: 3373–3385.
Sanders JE, Guthrie KA, Hoffmeister PA, Woolfrey AE, Carpenter PA, Appelbaum FR . Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood 2005; 105: 1348–1354.
Couto-Silva AC, Trivin C, Esperou H, Michon J, Baruchel A, Lemaire P et al. Final height and gonad function after total body irradiation during childhood. Bone Marrow Transplant 2006; 38: 427–432.
Sanders JE . Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant 2008; 41: 223–227.
Clement-De Boers A, Oostdijk W, Van Weel-Sipman MH, Van den Broeck J, Wit JM, Vossen JM . Final height and hormonal function after bone marrow transplantation in children. J Pediatr 1996; 129: 544–550.
Bakker B, Massa GG, Oostdijk W, Van Weel-Sipman MH, Vossen JM, Wit JM . Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies. Eur J Pediatr 2000; 159: 31–37.
Frisk P, Arvidson J, Gustafsson J, Lonnerholm G . Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant 2004; 33: 205–210.
Bakker B, Oostdijk W, Geskus RB, Stokvis-Brantsma WH, Vossen JM, Wit JM . Patterns of growth and body proportions after total-body irradiation and hematopoietic stem cell transplantation during childhood. Pediatr Res 2006; 59: 259–264.
Michel G, Bordigoni P, Simeoni MC, Curtillet C, Hoxha S, Robitail S et al. Health status and quality of life in long-term survivors of childhood leukaemia: the impact of haematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40: 897–904.
Marshall WA, Tanner JM . Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291–303.
Marshall WA, Tanner JM . Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13–23.
Sempé M, Pédron G, Roy-Pernot M-P . Auxologie, méthode et séquences. Théraplix: Paris, 1979, pp 124.
Bordigoni P, Esperou H, Souillet G, Pico J, Michel G, Lacour B et al. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Societe Francaise de Greffe de Moelle study. Br J Haematol 1998; 102: 656–665.
Cohen A, Rovelli A, Bakker B, Uderzo C, van Lint MT, Esperou H et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT. Blood 1999; 93: 4109–4115.
Bakker B, Oostdijk W, Bresters D, Walenkamp MJ, Vossen JM, Wit JM . Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant 2004; 33: 1049–1056.
Giorgiani G, Bozzola M, Locatelli F, Picco P, Zecca M, Cisternino M et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995; 86: 825–831.
Shankar SM, Bunin NJ, Moshang Jr T . Growth in children undergoing bone marrow transplantation after busulfan and cyclophosphamide conditioning. J Pediatr Hematol Oncol 1996; 18: 362–366.
Afify Z, Shaw PJ, Clavano-Harding A, Cowell CT . Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant 2000; 25: 1087–1092.
Thomas BC, Stanhope R, Plowman PN, Leiper AD . Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. Eur J Pediatr 1993; 152: 888–892.
Chemaitilly W, Boulad F, Heller G, Kernan NA, Small TN, O’Reilly RJ et al. Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone Marrow Transplant 2007; 40: 29–35.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bernard, F., Bordigoni, P., Simeoni, MC. et al. Height growth during adolescence and final height after haematopoietic SCT for childhood acute leukaemia: the impact of a conditioning regimen with BU or TBI. Bone Marrow Transplant 43, 637–642 (2009). https://doi.org/10.1038/bmt.2008.370
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.370
Keywords
This article is cited by
-
Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study
Bone Marrow Transplantation (2020)
-
Growth impairment after TBI of leukemia survivors children: a model- based investigation
Theoretical Biology and Medical Modelling (2014)
-
Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study
Bone Marrow Transplantation (2014)
-
Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA)
Bone Marrow Transplantation (2012)
-
État de santé et qualité de vie à long terme après guérison d’un cancer traité durant l’enfance
Oncologie (2011)